Back to Superinvestors
SUPERINVESTOR HOLDERS

TSHA

Taysha Gene Therapies Inc
Healthcare · Biotechnology
Holders
2
Total value
$16,199,383
Total shares
2,378,764
Cross-link
Financials →
Investor Shares Value % of Portfolio Activity As of
Tom Steyer
Farallon Capital Management LLC
2,250,000 $15,322,500 0.07% NEW +2,250,000 30 Jun 2026
Cliff Asness
AQR Capital Management
128,764 $876,883 0.00% REDUCE -48,545 30 Jun 2026